Joshua Silverman is Director of MyMD Pharmaceuticals, Inc.. Currently has a direct ownership of 88,775 shares of MYMD, which is worth approximately $151,805. The most recent transaction as insider was on Nov 26, 2021, when has been sold 5,000 shares (Common Stock) at a price of $7.55 per share, resulting in proceeds of $37,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.8K
0% 3M change
0% 12M change
Total Value Held $151,805

Joshua Silverman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 26 2021
BUY
Open market or private purchase
$37,750 $7.55 p/Share
5,000 Added 5.33%
88,775 Common Stock
Nov 24 2021
BUY
Open market or private purchase
$67,000 $6.7 p/Share
10,000 Added 10.66%
83,775 Common Stock
Apr 16 2021
SELL
Payment of exercise price or tax liability
$189,326 $4.94 p/Share
38,325 Reduced 35.0%
71,175 Common Stock
Apr 16 2021
BUY
Exercise of conversion of derivative security
-
109,500 Added 49.41%
112,101 Common Stock

Also insider at

AYRO
AYRO, Inc. Consumer Cyclical
PTPI
Petros Pharmaceuticals, Inc. Healthcare
SNPX
Synaptogenix, Inc. Healthcare
FEMY
FEMASYS INC Healthcare
PMCB
PharmaCyte Biotech, Inc. Healthcare
JS

Joshua Silverman

Director
Round Rock, TX

Track Institutional and Insider Activities on MYMD

Follow MyMD Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYMD shares.

Notify only if

Insider Trading

Get notified when an My Md Pharmaceuticals, Inc. insider buys or sells MYMD shares.

Notify only if

News

Receive news related to MyMD Pharmaceuticals, Inc.

Track Activities on MYMD